Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Best-performing Canadian Nickel Stocks of 2024
next post
Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt

Related Posts

10 Silver ETFs for Every Investing Style in...

June 19, 2025

AI Market 2024 Year-End Review

December 18, 2024

Charbone Hydrogen Announces Q1 2025 Financial Results

May 31, 2025

Jindalee Realises $2.75M from Sale of Non-Core Asset

February 25, 2025

Maiden Underground Ore Reserves Underpins FY26 Production

June 26, 2025

Lode Gold Closes $350,000 Financing

January 1, 2025

Chris Berry: The West Must Invest in Refinement...

July 11, 2025

Syntheia Provides Telemarketer Services for Political Campaign in...

April 12, 2025

​Royal Gold to Create Streaming and Royalty Giant...

July 11, 2025

Crypto Market Recap: Crypto Rallies As “Big, Beautiful...

July 5, 2025

Recent Posts

  • Tech Takes the Spotlight Again—Are You Watching These Stocks?
  • This Tool Could Change Your Options Trading Forever
  • Four Symbols, One Big Message: What the Charts are Telling Us
  • 30 Dow Stocks in 20 Minutes: Joe Rabil’s Mid-Year Technical Check
  • Simpler Charts, Better Results? Use This Trick to Trade Smarter With Less

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • Tech Takes the Spotlight Again—Are You Watching These Stocks?

    July 17, 2025

  • This Tool Could Change Your Options Trading Forever

    July 17, 2025

  • Four Symbols, One Big Message: What the Charts are Telling Us

    July 17, 2025

  • 30 Dow Stocks in 20 Minutes: Joe Rabil’s Mid-Year Technical Check

    July 17, 2025

  • Simpler Charts, Better Results? Use This Trick to Trade Smarter With Less

    July 17, 2025

  • Congress considers permanent national park fee increase for international visitors

    July 17, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 3

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 4

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 5

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
  • 6

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 7

    Trudeau declares himself ‘proud feminist’ after lamenting Harris loss to Trump as setback for women

    December 13, 2024
Promotion Image

banner

Categories

  • Business (454)
  • Investing (1,578)
  • Politics (1,947)
  • Stocks (659)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved